Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | PTPN1 | P18031 | 4/20 | 0.36 |
| ▸ | CA1 | P00915 | 2/20 | 0.36 |
| ▸ | CA2 | P00918 | 2/20 | 0.36 |
| ▸ | CA9 | Q16790 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22821594 | 0.96 | ALDH1A1 (0.39) | POLBGAAPTPN1CA1CA2 | |
| SCHEMBL9912672 | 0.86 | ALDH1A1 (0.41) | POLBGAAPTPN1CA1CA2 | |
| SCHEMBL16488176 | 0.86 | ALDH1A1 (0.41) | POLBGAAPTPN1CA1CA2 | |
| SCHEMBL803271 | 0.86 | ALDH1A1 (0.41) | POLBGAAPTPN1CA1CA2 | |
| SCHEMBL17127373 | 0.86 | ALDH1A1 (0.41) | POLBGAAPTPN1CA1CA2 | |
| SCHEMBL18503096 | 0.86 | ALDH1A1 (0.41) | POLBGAAPTPN1CA1CA2 | |
| SCHEMBL7026542 | 0.83 | PTPN1 (0.44) | POLBGAAPTPN1CA1CA2 | |
| SCHEMBL3546297 | 0.83 | PTPN1 (0.44) | POLBGAAPTPN1CA1CA2 | |
| SCHEMBL5350100 | 0.83 | PTPN1 (0.44) | POLBGAAPTPN1CA1CA2 | |
| SCHEMBL5390328 | 0.83 | PTPN1 (0.44) | POLBGAAPTPN1CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11117996-B2 | Self-assembly composition for pattern formation and pattern forming method | Oji Holdings Corporation (JP) | 2021-09-14 | — | — | US | disclosed |
| US-20210147603-A1 | SELF-ASSEMBLY COMPOSITION FOR PATTERN FORMATION AND PATTERN FORMING METHOD | Oji Holdings Corporation (JP) | 2021-05-20 | — | — | US | disclosed |
| US-20190211130-A1 | SELF-ASSEMBLY COMPOSITION FOR PATTERN FORMATION AND PATTERN FORMING METHOD | Oji Holdings Corporation (JP) | 2019-07-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11117996-B2 | Self-assembly composition for pattern formation and pattern forming method | IAPP, SAMM50, MAN1B1 | POLB 499/4885GAA 920/4885PTPN1 2246/4885 |
| US-20190211130-A1 | SELF-ASSEMBLY COMPOSITION FOR PATTERN FORMATION AND PATTERN FORMING METHOD | IAPP, SAMM50, MAN1B1 | POLB 499/4885GAA 920/4885PTPN1 2246/4885 |
| US-20210147603-A1 | SELF-ASSEMBLY COMPOSITION FOR PATTERN FORMATION AND PATTERN FORMING METHOD | IAPP, SAMM50, MAN1B1 | POLB 499/4885GAA 920/4885PTPN1 2246/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.